Correlation Between Moleculin Biotech and Verrica Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Moleculin Biotech and Verrica Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Moleculin Biotech and Verrica Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Moleculin Biotech and Verrica Pharmaceuticals, you can compare the effects of market volatilities on Moleculin Biotech and Verrica Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Moleculin Biotech with a short position of Verrica Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Moleculin Biotech and Verrica Pharmaceuticals.
Diversification Opportunities for Moleculin Biotech and Verrica Pharmaceuticals
0.54 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between Moleculin and Verrica is 0.54. Overlapping area represents the amount of risk that can be diversified away by holding Moleculin Biotech and Verrica Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Verrica Pharmaceuticals and Moleculin Biotech is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Moleculin Biotech are associated (or correlated) with Verrica Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Verrica Pharmaceuticals has no effect on the direction of Moleculin Biotech i.e., Moleculin Biotech and Verrica Pharmaceuticals go up and down completely randomly.
Pair Corralation between Moleculin Biotech and Verrica Pharmaceuticals
Given the investment horizon of 90 days Moleculin Biotech is expected to generate 1.62 times more return on investment than Verrica Pharmaceuticals. However, Moleculin Biotech is 1.62 times more volatile than Verrica Pharmaceuticals. It trades about -0.24 of its potential returns per unit of risk. Verrica Pharmaceuticals is currently generating about -0.4 per unit of risk. If you would invest 258.00 in Moleculin Biotech on October 9, 2024 and sell it today you would lose (79.00) from holding Moleculin Biotech or give up 30.62% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Moleculin Biotech vs. Verrica Pharmaceuticals
Performance |
| Timeline |
| Moleculin Biotech |
| Verrica Pharmaceuticals |
Moleculin Biotech and Verrica Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Moleculin Biotech and Verrica Pharmaceuticals
The main advantage of trading using opposite Moleculin Biotech and Verrica Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Moleculin Biotech position performs unexpectedly, Verrica Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Verrica Pharmaceuticals will offset losses from the drop in Verrica Pharmaceuticals' long position.| Moleculin Biotech vs. Pulmatrix | Moleculin Biotech vs. Cyclacel Pharmaceuticals | Moleculin Biotech vs. Akari Therapeutics PLC | Moleculin Biotech vs. Bio Path Holdings |
| Verrica Pharmaceuticals vs. Inventiva Sa | Verrica Pharmaceuticals vs. Edgewise Therapeutics | Verrica Pharmaceuticals vs. Vigil Neuroscience | Verrica Pharmaceuticals vs. Connect Biopharma Holdings |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Sign In To Macroaxis module to sign in to explore Macroaxis' wealth optimization platform and fintech modules.
Other Complementary Tools
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance |